Compare · DWSH vs GNOM

DWSH vs GNOM

Side-by-side comparison of AdvisorShares Dorsey Wright Short ETF (DWSH) and Global X Genomics & Biotechnology ETF (GNOM): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DWSH and GNOM operate in n/a (n/a), so they compete in similar markets.
MetricDWSHGNOM
Company
AdvisorShares Dorsey Wright Short ETF
Global X Genomics & Biotechnology ETF
Price
-
-
Market cap
-
-
1M return
-4.29%
-
1Y return
-27.27%
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
n/a
n/a
News (4w)
0
0
Recent ratings
0
0
DWSH

AdvisorShares Dorsey Wright Short ETF

The investment seeks capital appreciation through short selling securities. Dorsey, Wright & Associates, LLC (the "Sub-Advisor"), the sub-advisor to the fund, seeks to achieve the fund's investment objective by obtaining short exposure to investment returns of the broad U.S. large-capitalization equity market by engaging in short sales of U.S.-traded equity securities and exchange-traded funds ("ETFs"). Under normal circumstances, it invests at least 80% of its net assets (plus any borrowings for investment purposes) in investments that create or result in short exposure to U.S. equity securities.

GNOM

Global X Genomics & Biotechnology ETF

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.